The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 15, 2020

Filed:

Apr. 05, 2016
Applicant:

Torrent Pharmaceuticals Limited, Ahmedabad, IN;

Inventors:

Chaitanya Dutt, Gandhinagar, IN;

Jaya Abraham, Gandhinagar, IN;

Vivek Mishra, Gandhinagar, IN;

Amit Kesarwani, Gandhinagar, IN;

Ramesh Chandra Gupta, Gandhinagar, IN;

Shailesh Deshpande, Gandhinagar, IN;

Shital Kumar Zambad, Gandhinagar, IN;

Anoop Mathur, Gandhinagar, IN;

Jignesh Kotecha, Gandhinagar, IN;

Sachin Latad, Gandhinagar, IN;

Manish Patel, Gandhinagar, IN;

Anita Chaudhari, Gandhinagar, IN;

Assignee:

Torrent Pharmaceuticals Limited, Gujarat, Ahmedabad, IN;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4436 (2006.01); A61K 47/54 (2017.01); A61K 47/12 (2006.01); A61K 47/02 (2006.01); A61P 3/10 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4436 (2013.01); A61K 9/0095 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2054 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/541 (2017.08); A61P 3/10 (2018.01);
Abstract

This invention relates to pharmaceutical formulations comprising 1-(2-thien-2'-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2′-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof. The formulations of this invention are for treating diseases associated with advanced glycation end products.


Find Patent Forward Citations

Loading…